The Effects of Vitamin D2 Supplement During Pregnancy
1 other identifier
interventional
60
1 country
1
Brief Summary
The effects of vitamin D2 supplement during pregnancy on postpartum maternal and fetal vitamin D levels: the randomized controlled trial
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2018
CompletedFirst Posted
Study publicly available on registry
November 16, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2020
CompletedDecember 3, 2024
October 1, 2018
14 days
November 14, 2018
November 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
effect of vitamin D 2 supplementation during pregnancy
To study the effect of vitamin D 2 supplementation during pregnancy on postpartum maternal and fetal vitamin D levels effects of vitamin D2 supplement during pregnancy on postpartum maternal and fetal vitamin D levels
within 30 minute after delivered
Secondary Outcomes (2)
vitamin D levels in maternal blood during pregnancy
at first time ANC
vitamin D levels in maternal blood after vitamin D supplementation
within 30 minute after delivered
Study Arms (2)
Oral calciferol group
EXPERIMENTALSubjects will receive oral calciferol 20,000 iu per week during pregnancy until delivered
oral placebo group
PLACEBO COMPARATORSubjects will receive oral placebo 1 tab per week during pregnancy until delivered
Interventions
Eligibility Criteria
You may qualify if:
- Women who have pregnant and ANC at Rajavithi hospital
- Women who have age at least 18 year
- Women who have Thai nationality
- Women who have pregnant of gestational age under 20week
You may not qualify if:
- Women who don't plan of delivered at Rajavithi hospital
- Women who have complication of pregnancy
- Woman who delivered before gestational age 37week
- Women who have abnormal kidney function
- Woman who have been used anticonvulsant drug or others form of vitamin d
- Women who have vitamin d allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rajavithi hospital
Bangkok, Thailand, 10400, Thailand
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patitta Vacharaprechaskul
Department of Medical Services Ministry of Public Health of Thailand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2018
First Posted
November 16, 2018
Study Start
November 1, 2018
Primary Completion
November 15, 2018
Study Completion
May 30, 2020
Last Updated
December 3, 2024
Record last verified: 2018-10